Trial
NCT05284019
Real World Effectiveness of Eptinezumab in Participants With Migraine
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
H. Lundbeck A/S
Collaborators
—
Condition
Migraine
Intervention
Eptinezumab
Why stopped
The study was terminated due to enrolment challenges.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-29